Want to see PRAX full AI Analyst Report?
Total Valuation
Praxis Precision Medicines has a market cap or net worth of $8.58B. The enterprise value is $8.52K.
Market Cap$8.58B
Enterprise Value$8.52K
Share Statistics
Praxis Precision Medicines has 27,878,775 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding27,878,775
Owned by Insiders8.07%
Owned by Institutions0.58%
Financial Efficiency
Praxis Precision Medicines’s return on equity (ROE) is -0.35 and return on invested capital (ROIC) is -37.14%.
Return on Equity (ROE)-0.35
Return on Assets (ROA)-0.32
Return on Invested Capital (ROIC)-37.14%
Return on Capital Employed (ROCE)-0.37
Revenue Per Employee0.00
Profits Per Employee-1.81M
Employee Count168
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Praxis Precision Medicines is ―. Praxis Precision Medicines’s PEG ratio is -0.68.
PE Ratio―
PS Ratio0.00
PB Ratio7.55
Price to Fair Value7.55
Price to FCF-26.63
Price to Operating Cash Flow-34.38
PEG Ratio-0.68
Income Statement
In the last 12 months, Praxis Precision Medicines had revenue of 0.00 and earned -303.27M in profits. Earnings per share was -13.48.
Revenue0.00
Gross Profit-140.00K
Operating Income-326.20M
Pretax Income-303.27M
Net Income-303.27M
EBITDA-303.13M
Earnings Per Share (EPS)-13.48
Cash Flow
In the last 12 months, operating cash flow was -305.69M and capital expenditures -307.00K, giving a free cash flow of -306.00M billion.
Operating Cash Flow-305.69M
Free Cash Flow-306.00M
Free Cash Flow per Share-10.98
Dividends & Yields
Praxis Precision Medicines pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.11
52-Week Price Change702.58%
50-Day Moving Average306.02
200-Day Moving Average289.57
Relative Strength Index (RSI)64.02
Average Volume (3m)493.75K
Important Dates
Praxis Precision Medicines upcoming earnings date is Nov 11, 2026, Before Open (Confirmed).
Last Earnings DateAug 6, 2026
Next Earnings DateNov 11, 2026
Ex-Dividend Date―
Financial Position
Praxis Precision Medicines as a current ratio of 10.22, with Debt / Equity ratio of 0.08%
Current Ratio10.22
Quick Ratio10.22
Debt to Market Cap0.00
Net Debt to EBITDA1.18
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Praxis Precision Medicines has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Praxis Precision Medicines EV to EBITDA ratio is -20.70, with an EV/FCF ratio of -25.19.
EV to Sales0.00
EV to EBITDA-20.70
EV to Free Cash Flow-25.19
EV to Operating Cash Flow-25.20
Balance Sheet
Praxis Precision Medicines has $758.55M in cash and marketable securities with $1.09M in debt, giving a net cash position of $757.46M billion.
Cash & Marketable Securities$758.55M
Total Debt$1.09M
Net Cash$757.46M
Net Cash Per Share$27.17
Tangible Book Value Per Share$39.02
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Praxis Precision Medicines is $615.18, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$615.18
Price Target Upside89.11% Upside
Analyst ConsensusStrong Buy
Analyst Count18
Revenue Growth Forecast-100.00%
EPS Growth Forecast-24.90%